Auckland, New Zealand

Christina Maree Buchanan

USPTO Granted Patents = 2 

 

Average Co-Inventor Count = 3.3

ph-index = 1


Company Filing History:


Years Active: 2013-2021

Loading Chart...
Loading Chart...
2 patents (USPTO):

Title: Christina Maree Buchanan: Innovator in Pharmaceutical Compounds

Introduction

Christina Maree Buchanan is a prominent inventor based in Auckland, New Zealand. She has made significant contributions to the field of pharmaceuticals, particularly in the development of innovative compounds for medical treatments. With a total of 2 patents, her work focuses on addressing various diseases and conditions through her unique inventions.

Latest Patents

Christina's latest patents include "Tricyclic heterocyclic derivatives and uses thereof" and "Vesiculins." The first patent discloses tricyclic heterocyclic compounds that exhibit kinase inhibitory activity. These compounds are utilized in pharmaceutical compositions and kits for treating diseases mediated by CSF-1R, including cancers and autoimmune conditions. The second patent relates to vesiculin peptides and their derivatives, which are designed to improve glucose metabolism and treat related disorders.

Career Highlights

Christina is associated with Auckland Uniservices Limited, where she continues to advance her research and development efforts. Her innovative approach has positioned her as a key figure in the pharmaceutical industry, contributing to the creation of effective treatments for complex health issues.

Collaborations

Christina has collaborated with notable colleagues, including Swarnalatha Akuratiya Gamage and Peter Robin Shepherd. These partnerships have enhanced her research capabilities and broadened the impact of her inventions.

Conclusion

Christina Maree Buchanan exemplifies the spirit of innovation in the pharmaceutical field. Her patents and ongoing research contribute significantly to medical advancements, showcasing her dedication to improving health outcomes.

This text is generated by artificial intelligence and may not be accurate.
Please report any incorrect information to support@idiyas.com
Loading…